46 reports

  • Risk Factors and Comorbidities for Type 1 Diabetes
  • 3.5.1 Diagnosed Prevalent Cases of Type 1 Diabetes

ua=## (Accessed: ## April 2019).

  • Type 1 Diabetes
  • Canada
  • United States
  • World
  • Forecast

Disease Analysis: Type ## Diabetes ## OVERVIEW ## Latest key takeaways ## DISEASE BACKGROUND ## Disease definition ## Patient segmentation ## Disease diagnosis ## TREATMENT ## Daily insulin replacement therapy is required to prevent hyperglycemia ## EPIDEMIOLOGY ## Prevalence in adults (##

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • United States
  • Forecast

Type ## Diabetes KOL Interview – UK This interview with a UK Key Opinion Leader (KOL) provides insight into current therapies for type ## diabetes, as well as pricing pressures within the diabetes market, the unmet needs in type ## diabetes, and upcoming therapies in the pipe

  • Chronic Disease
  • Diabetes
  • Type 1 Diabetes
  • United Kingdom
  • Market Size

Type ## Diabetes KOL Interview – US, Midwest This interview with a US Key Opinion Leader (KOL) provides insight into current therapies for type ## diabetes, as well as pricing pressures within the diabetes market, the unmet needs in type ## diabetes, and upcoming therapies in

  • Chronic Disease
  • Diabetes
  • Type 1 Diabetes
  • United States
  • Market Size

Type ## Diabetes Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Chronic Disease
  • Type 1 Diabetes
  • APAC
  • World
  • Demand

Diabetes Type ## Market and Forecast Analysis to 2025 CONTENTS ## FORECAST: TYPE ## DIABETES (Published on ## June 2017) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## MARKET DEFINITION AND METHODOLOGY ## LATEST ANALYST OPINION ## APIDRA (INSULIN GLULISINE) ##

  • Type 1 Diabetes
  • European Union
  • Japan
  • United States
  • Demand
  • 4.2.3 Type 1 Diabetes Market and Forecast
  • GLOBAL - TYPE 1 DIABETES DIAGNOSTICS MARKET (MILLION US$), 2011 - 2018

In United Kingdom, an estimated of ## in every ##-## people under the age of ## have Type ## diabetes.

  • Type 1 Diabetes
  • World
  • Market Size
  • bioMerieux S.A.
  • Roche Group

Global Type ## Diabetes Epidemiology and Patient Flow Analysis - 2017 ##.

  • Chronic Disease
  • Type 1 Diabetes
  • United States
  • World
  • Forecast

Type ## Diabetes (T##D) Market Size, Forecast And Trend Analysis, 2014 - 2024 Chapter ##.

  • Insulin
  • Therapy
  • Type 1 Diabetes
  • United States
  • Forecast
  • TOP-LINE PREVALENCE FOR TYPE 1 DIABETES MELLITUS
  • Prevalence of Type 1 Diabetes Mellitus, females (000s)

Prevalence of Type ## Diabetes Mellitus, males (##s) Table ##.

  • Chronic Disease
  • Diabetes
  • Pathology
  • Type 1 Diabetes

Europe Type ## Diabetes Epidemiology and Patient Flow Analysis - 2017 ##.

  • Type 1 Diabetes
  • Europe
  • France
  • Germany
  • Forecast

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Market Shares
  • Market Size
  • Type 1 Diabetes
  • TYPE 1 DIABETES WITH HYPOGLYCEMIA

THE COMPANY CLAIMS THAT DIABECELL IS EXPECTED TO BE ONE OF THE NOVEL THERAPEUTIC OPTIONS FOR REFRACTORY TYPE ## DIABETES. ##. ##. ##. ##.

  • Hospital
  • Type 1 Diabetes
  • United States
  • Erytech Pharma SA
  • Neurotech Pharmaceuticals, Inc.
  • TYPE 1 DIABETES DRUGS MARKET IN EMEA 2015-2020 ($ BILLIONS)
  • SEGMENTATION OF TYPE 1 DIABETES DRUGS MARKET BY DRUG CLASS

Phase II Type ## diabetes Type ## Diabetes ANTI-IL ## T##D (NN##) TEPLIZUMAB (MGA##) PROCHYMAL MacroGenics Company Stage of development Indication OI##GT (NN1953) Novo Nordisk ULTRA-RAPID INSULIN Eli Lilly PF-## BHV## HIP-##B NN1956 Pfizer BHV Pharma CureDm Novo Nordisk P

  • Diabetes
  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Market Shares
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Japan
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • United States
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Italy
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Germany
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • United Kingdom
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • France
  • Market Size

Type ## Diabetes Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Pathology
  • Type 1 Diabetes
  • Spain
  • Market Size

Type ## Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trial

  • Chronic Disease
  • Clinical Trial
  • Therapy
  • Type 1 Diabetes
  • World

Drug analysis: Farxiga

8770 10000 7800

Drug analysis: Farxiga PRODUCT PROFILES Farxiga : Diabetes type ## Farxiga : Diabetes type ## LIST OF FIGURES Figure ##: Farxiga for type ## diabetes – SWOT analysis Figure ##: Datamonitor Healthcare drug assessment of Farxiga Figure ##: Datamonitor Healthcare drug assessment scorecard

  • Diabetes
  • Type 1 Diabetes
  • European Union
  • Japan
  • United States
  • L: EUROPE REGIONAL MARKERS: HISTORIC AND FORECAST
  • Europe Insulin Pumps Market, By Value

Insulin Pumps Outlook Type I Diabetes: Type I diabetes is an autoimmune disease that destroys the insulin producing beta cells in the pancreas of the human body.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

Insulin Glargine in Patients with Type ## Diabetes ## Jun ##, 2018: Xeris Pharmaceuticals Announces Positive Phase ## Clinical Trial Data on Its Investigational Ready-to-Use Glucagon Rescue Pen ## Jun ##, 2018: Adding Liraglutide to Insulin Regimen for People with Type ## Diabetes Improved Gly

  • Chronic Disease
  • Clinical Trial
  • Therapy
  • Type 1 Diabetes
  • World
  • TYPE 1 DIABETES (JUVENILE DIABETES)
  • TYPE 1 DIABETES (JUVENILE DIABETES)

Similarly, the Universities portfolio in Phase II, Phase I, Phase ##, Preclinical and Discovery stages comprises ##, ##, ##, ## and ## molecules, respectively.

  • Chronic Disease
  • Pathology
  • Therapy
  • Type 1 Diabetes
  • Product Initiative

The report focuses on drugs and therapies being evaluated for Type ## Diabetes (Juvenile Diabetes) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Chronic Disease
  • Clinical Trial
  • Pathology
  • Type 1 Diabetes

2019 Type ## Diabetes Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Type 1 Diabetes
  • APAC
  • BIOARTIFICIAL PANCREAS - TYPE 1 DIABETES - PRODUCT STATUS
  • BIOARTIFICIAL PANCREAS - TYPE 1 DIABETES - PRODUCT DESCRIPTION

According to the International Diabetes Federation, there were more than one million children with type ## diabetes in 2017.

  • Clinical Trial
  • Diabetes Monitoring
  • Type 1 Diabetes
  • United States
  • Medtronic, Inc.